
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606020630PRIMZONEFULLFEED9729756) on June 02, 2026, and is solely responsible for the information contained therein.